eretide Accuhaler 50/500 mcg is a multi-dose dry powder inhaler (DPI) combining salmeterol (long-acting β₂-agonist) and fluticasone propionate (corticosteroid). This device delivers dual-action maintenance therapy in well-calibrated doses, enabling improved airflow and reduced inflammation, particularly beneficial for patients with moderate to severe asthma and COPD.
Select options
This product has multiple variants. The options may be chosen on the product page
Serobid Rotacaps are dry-powder inhalation capsules containing salmeterol, a long-acting β₂-agonist. Designed for use with a DPI device (e.g., Rotahaler), these capsules provide up to 24‑hour bronchodilation, easing airways, reducing breathlessness, and supporting effective lung function in patients with asthma or COPD.
Select options
This product has multiple variants. The options may be chosen on the product page
Seroflo Inhaler 125 mcg is a pressurized metered‑dose inhaler (MDI) delivering a fixed-dose blend of salmeterol (a long‑acting β₂‑agonist) and fluticasone propionate (a corticosteroid). Designed for consistent daily use, this inhaler offers dual-action therapy—opening airways and reducing inflammation—to manage symptoms of asthma and COPD effectively.
Select options
This product has multiple variants. The options may be chosen on the product page
Seroflo Inhaler 250 mcg is a pressurized metered‑dose inhaler (MDI) containing a fixed‑dose blend of salmeterol (long‑acting β₂‑agonist) and fluticasone propionate (corticosteroid). Designed for regular use, it delivers both bronchodilation and anti‑inflammatory effects to help manage asthma and COPD symptoms efficiently.
Select options
This product has multiple variants. The options may be chosen on the product page
Seroflo Inhaler 50 mcg is a pressurized metered‑dose inhaler (MDI) housing a fixed-dose combination of salmeterol (a long‑acting β₂-agonist) and fluticasone propionate (a corticosteroid). Designed for daily use, this inhaler delivers effective bronchodilation along with anti-inflammatory action, helping to control symptoms of asthma and COPD.
Seroflo MultiHaler is a multi-dose dry powder inhaler (DPI) combining salmeterol (long-acting β₂-agonist) and fluticasone propionate (corticosteroid). The device holds multiple pre-measured doses, making it easy to manage regular asthma or COPD therapy. Breath-activated delivery ensures an efficient mix of bronchodilation and inflammation control without the need for propellants.
Select options
This product has multiple variants. The options may be chosen on the product page
Seroflo Rotacaps 100 mcg are dry‑powder inhalation capsules that blend salmeterol (a long‑acting bronchodilator) and fluticasone propionate (a corticosteroid). Used with a compatible DPI device, these capsules offer sustained airway relaxation and reduced inflammation, making them ideal for managing asthma and chronic obstructive pulmonary disease (COPD).
Select options
This product has multiple variants. The options may be chosen on the product page
Seroflo Rotacaps 250 mcg are dry-powder inhalation capsules combining salmeterol (a long-acting β₂-agonist) and fluticasone propionate (a corticosteroid). Designed for use with dry-powder inhalers, these capsules provide sustained bronchodilation and anti-inflammatory benefits suitable for managing asthma and chronic obstructive pulmonary disease (COPD).
Select options
This product has multiple variants. The options may be chosen on the product page
Seroflo Rotacaps 500 mcg consists of dry-powder inhalation capsules that combine salmeterol (a long-acting β₂-agonist) and fluticasone propionate (a corticosteroid). These capsules, used with a DPI such as a Rotahaler, provide sustained bronchodilation and anti-inflammatory effects, ideal for the long-term management of asthma and chronic obstructive pulmonary disease (COPD).
Select options
This product has multiple variants. The options may be chosen on the product page
Singulair 10 mg is an oral tablet containing montelukast, a leukotriene receptor antagonist. It is indicated for adults and adolescents to manage chronic asthma, prevent exercise-induced bronchospasm, and relieve symptoms of seasonal or perennial allergic rhinitis by reducing inflammation and bronchoconstriction.
Select options
This product has multiple variants. The options may be chosen on the product page
Singulair 5 mg is a chewable montelukast tablet, a leukotriene receptor antagonist that helps reduce inflammation, airway constriction, and allergic responses. It’s indicated for children aged 6–14 to prevent asthma symptoms and manage seasonal or year-round allergic rhinitis.
Select options
This product has multiple variants. The options may be chosen on the product page
Symbicort Turbuhaler 160 mcg is a dry powder inhaler (DPI) delivering a fixed-dose combination of budesonide (anti-inflammatory) and formoterol (long-acting bronchodilator). Designed for asthma and COPD management, it addresses both chronic airway inflammation and provides rapid relief through a single, breath-activated inhaler device. It supports both daily maintenance and rescue use as clinically appropriate.
Select options
This product has multiple variants. The options may be chosen on the product page
End of content
End of content
Join our newsletter and get 20% off your first order
Subscribe to our newsletter and get the latest trending products and offers updates.
Wait! before you leave…
We have something special for you
Use above code to get 20% off for your first order when checkout. Don't miss it.
In order to provide you a personalized shopping experience, our site uses cookies. By continuing to use this site, you are agreeing to our cookie policy.